&w=3840&q=100)
Glenmark Pharmaceuticals shares up 3% on launching cancer drug Tevimbra
Around 1:05 PM, Glenmark Pharmaceuticals shares continued to trade higher, up 1.82 per cent at ₹1,712.50 per share. In comparison, BSE Sensex was trading 0.71 per cent higher at 82,636.70 levels.
Why did Glenmark Pharmaceuticals share price rise today?
Glenmark Pharmaceuticals share price gained in trade after the company announced the launch of Tevimbra (tislelizumab) in India, following approval by the Central Drugs Standard Control Organisation (CDSCO).
Tevimbra is a uniquely engineered anti-PD-1 monoclonal antibody developed by BeiGene (now BeOne Medicines), a global oncology innovator focused on delivering cutting-edge cancer therapies.
The drug is indicated for the first-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in combination with chemotherapy, and as a second-line monotherapy for both locally advanced/metastatic NSCLC and esophageal squamous cell carcinoma (ESCC).
The launch marks Glenmark Pharmaceuticals' entry into the immuno-oncology space in India and is a key step in broadening its oncology portfolio with innovative therapies.
NSCLC accounts for over 80 per cent of all lung cancer cases, while ESCC is the most prevalent histological subtype of esophageal cancer in India. Tevimbra addresses the major treatment needs of this large patient base with a differentiated and evidence-backed option, the company said.
Already approved and available in major markets including the US, EU, Australia, and China, Tevimbra is designed to selectively bind to PD-1 receptors, restoring T-cell function and limiting off-target immune suppression. It has shown strong efficacy and a favourable safety profile across various solid tumors in multiple Phase 3 studies and a global clinical programme.
Glenamark Pharmaceuticals Q4 results
For the fourth quarter of FY2024-25 (Q4FY25), Glenmark Pharmaceuticals reported a consolidated revenue of ₹3,256.2 crore, marking a year-on-year (Y-o-Y) growth of 6.3 per cent from ₹3,063 crore in the same period last year. The company's Ebitda for the quarter stood at ₹560.7 crore, up 11.2 per cent from ₹504.3 crore, with an Ebitda margin of 17.2 per cent. Adjusted Profit After Tax (PAT) for the quarter came in at ₹346.6 crore, reflecting an adjusted PAT margin of 10.6 per cent.
For the full fiscal year ended March 31, 2025 (FY25), the company's consolidated revenue rose 12.8 per cent to ₹13,321.7 crore, compared to ₹11,813.1 crore in the previous year. Ebitda for FY25 more than doubled to ₹2,351 crore from ₹1,195.3 crore, with the Ebitda margin improving to 17.6 per cent. The company also posted an adjusted PAT of ₹1,389.4 crore for the year, resulting in an adjusted PAT margin of 10.4 per cent.
About Glenmark Pharmaceuticals
Glenmark Pharmaceuticals is a research-driven global pharmaceutical company with a strong presence across Branded, Generics, and OTC segments. The company focuses on key therapeutic areas including respiratory, dermatology, and oncology.
With 11 state-of-the-art manufacturing facilities spread across four continents and operations in over 80 countries, Glenmark Pharmaceuticals has established itself as a major player in the global pharmaceutical landscape.
The market capitalisation of Glenmark Pharmaceuticals is ₹48,171.68 crore, according to BSE. The company falls under the BSE 500 index.
Glenmark Pharmaceuticals' 52-week high is ₹1,830.05 per share, while its 52-week low is ₹1,199.95 apiece.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Standard
an hour ago
- Business Standard
INR likely to limit gains amid dollar rebound
The Indian rupee could limit gains in opening trades on Wednesday tracking good rebound in dollar overseas. Yesterday, rupee appreciated 40 paise to close at 86.99 against the US dollar, supported by optimism over GST restructuring and positive domestic equity markets. Indian shares rose modestly on Tuesday, extending gains from the previous session amid hopes that Prime Minister Modi's recent GST reforms will potentially ease inflation and pave the way for further rate cuts by the Reserve Bank of India (RBI). Investor sentiment was also underpinned by renewed diplomatic efforts aimed at ending the war in Ukraine and improving Sino-India relations amidst global uncertainty. The benchmark BSE Sensex rose 370.64 points, or 0.46 percent, to 81,644.39 while the broader NSE Nifty index closed up 103.70 points, or 0.42 percent, at 24,980.65.
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
Breakout stock: Ola Electric shares sprint 23% in 2 days on volume surge
Ola Electric shares have seen hge volume surge on the counter over the past two days amid bulk deals. Technical charts show a "strong buy signal" for the electric two-wheeler stock New Delhi Ola Electric share price today In a dramatic turnaround in their market moves, Ola Electric shares have been moving higher on the bourses over the past two days, aided by heavy volumes. The stock of the electric two-wheeler manufacturer zoomed 14.5 per cent on the BSE in the intraday trade on Wednesday, adding on to the 8.7-per cent stock rally seen on Tuesday. By comparison, the BSE Sensex was up 143 points (0.21 per cent) at 10:45 AM. Ola Electric volume surge Till the time of writing this report, roughly 36 million shares had changed hands on the BSE as against a two-week average of 12.9 million shares. Combined with the volume on the National Stock Exchange (NSE), 520.3 million shares have changed hands on the Ola counter so far in the session. Notably, 580 million shares of Ola Electric changed hands on the bourses on Tuesday, the highest in a month. NSE's bulk deal data shows that Graviton Research Capital LLP bought 3,20,44,542 (32.04 million) Ola shares at a price of ₹44.13 per share and sold 3,20,38,456 (32.03 million) shares at a price of ₹44.16 per share on Tuesday. Similarly, Hrti Private Ltd bought 3,56,98,031 (35.69 million) shares at a price of ₹44.26 per share and sold 2,77,29,731 (27.72 million) shares of Ola Electric at a price of ₹44.15 per share yesterday. Should you buy Ola Electric shares now? According to analysts at Systematix Group, Ola Electric shares have given a decisive bullish breakout above ₹44.8 per share levels, backed by a strong price action and above-average volumes. This, the brokerage said, suggests a 'start of a fresh upward trend'. "The stock not only closed above its 20-day and 50-day simple moving average (SMA) on Tuesday, confirming a positive shift in the short-to-medium term outlook, but has demonstrated resilience by defending the crucial support zone of ₹39.80-₹40.80 levels," it said in a note on Wednesday. The brokerage believes the rebound in Ola Electric shares has paved for a 'higher high-higher low' formation on technical charts, reinforcing strength in the ongoing momentum. Moreover, the stock has broken out of the upper end of the Bollinger Band, indicating a volatility expansion on the upside and "generating a fresh buy signal". "This structure creates the best risk-reward ratio. Investors can buy Ola Electric shares in the cash market at ₹44.90-₹43 zone, with a strict stop loss of ₹40. The near-term targets are ₹49.80-₹55," Systematix Group said.
&w=3840&q=100)
Business Standard
2 hours ago
- Business Standard
Mukul Agrawal portfolio stock zooms nearly 200% in 5 months. Do you own?
Share price of ASM Technologies Shares of ASM Technologies hit a new high of ₹3,634, as they rallied 10 per cent on the BSE in Wednesday's intra-day trade. In the past three trading days, the stock price of the smallcap company has surged 33 per cent. In the past five months, the stock has zoomed 197 per cent from a level of ₹1,223.80 on the BSE. At 10:12 AM; ASM Technologies was trading 9 per cent higher at ₹3,597, as compared to 0.01 per cent rise in the BSE Sensex. The company market capitalisation stands at ₹4,244 crore. Mukul Agrawal held nearly 12% stake in ASM Technologies Investor Mukul Mahavir Agrawal held 1.52 million equity shares representing 11.7 per cent stake in ASM Technologies as on August 6, 2025, the shareholding pattern data shows. Mukul Agrawal held 762,500 equity shares or 6.48 per cent holding in the company at the end of June 30, 2025 quarter, data shows. Strong Q1FY26 results For the April to June 2025 quarter (Q1FY26), ASM Technologies reported a consolidated profit after tax (PAT) of ₹15.6 crore, on the back of strong operational performance. The company had posted PAT of ₹2.5 crore in a year ago quarter. Revenue from operations more-than-doubled to ₹122.90 crore from ₹52.6 crore, driven by strong performance in both the company's design-led Manufacturing and Engineering R&D segments. Earnings before interest, taxes, depreciation, amortization (EBITDA) margin improved to 20.9 per cent from 7.3 per cent. Industry Outlook The outlook for the Engineering Research & Development (ER&D) sector in India is optimistic, with projected growth driven by advancements in digital engineering and sustainability initiatives. By 2030, the industrial ER&D spend is expected to reach $250-280 billion, growing at a CAGR of 8-9 per cent. As per Nasscom report key growth drivers include the increased adoption of automation, robotics, and AI-enhanced analytics. In addition, the focus on developing integrated product-service solutions is expected to contribute significantly to the sector's expansion as companies look to offer comprehensive solutions that enhance customer experience and operational efficiency, ASM Technologies had said in its FY24 annual report. Meanwhile, the NASSCOM Annual Enterprise CXO Survey 2025 highlights a shift toward AI-driven digital transformation, with organizations increasingly consolidating technology investments into high-impact use cases that are expected to define the next five years. About 82 per cent of CXOs plan to increase digital spending by 5 per cent plus compared to CY24, LTIMindtree, the peer group company, said in its FY25 annual report. Looking ahead, technology providers anticipate stronger growth in FY26, with 77 per cent expecting higher technology spending, fueled by foundational digital scope, emerging markets, and AIled innovation. However, cautious optimism prevails as AI-driven service transformation, skill shortages, cybersecurity risks, and margin pressures remain key challenges. Additionally, geopolitical uncertainties and trade policy shifts continue to influence market dynamics. About ASM Technologies With over three decades of experience, ASM Technologies has been supporting customers in the areas of Engineering Design led Manufacturing (DLM). ASM has multiple delivery locations in India with a global presence in USA, Singapore, UK, Canada, Japan, Thailand and Mexico. The company's Global Delivery Model and core competencies consider the changing economic scenarios as an opportunity to provide greater value to existing clients and add new clients. The company's specific industry, domain, and technology expertise allows it to facilitate business transformation for its clients through innovative strategies and solutions.
